Baron Funds, an investment management company, released its “Baron Discovery Fund” second-quarter 2025 investor letter. A ...

Topline results from the SURPASS-CVOT trial show that once-weekly tirzepatide has a cardiovascular risk profile similar to ...

A 65-year-old recently retired man presents to the office for his “Welcome to Medicare” exam.The patient retired from his job as an accountant about 3 months ago. His only past medical history, ...

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, ...